Dokumendiregister | Terviseamet |
Viit | 10.2-6/24/476-1 |
Registreeritud | 18.06.2024 |
Sünkroonitud | 19.06.2024 |
Liik | Sissetulev dokument |
Funktsioon | 10.2 Toodete terviseohutusega seotud toimingud |
Sari | 10.2-6 Teabenõuded, selgitustaotlused, märgukirjad toodete ohutuse valdkonnas |
Toimik | 10.2-6/2024 |
Juurdepääsupiirang | Avalik |
Juurdepääsupiirang | |
Adressaat | European Chemicals Agency |
Saabumis/saatmisviis | European Chemicals Agency |
Vastutaja | Aljona Honga (TA, Peadirektori asetäitja (1) vastutusvaldkond, Kemikaaliohutuse osakond) |
Originaal | Ava uues aknas |
15 May 2024
1 (2)
P.O. Box 400, FI-00121 Helsinki, Finland | Tel. +358 9 686180 | echa.europa.eu inv1/m11.0/t11.3/2024-05-15 03:37:45 dgt5.4.0
REACHLINKED OÜ Ahtri tn 12 10151, Tallinn Estonia
Registration number: 01-2119453158-37-0072
Registration date: 20 April 2021 Communication number: CMF-C-2114682529-33-01/F EC number: 203-080-7
INVALIDATION OF YOUR REGISTRATION
Based on Article 50(3) of Regulation (EC) No 1907/2006 (‘REACH’), Your registration for the substance with EC number 203-080-7 has been invalidated.
Procedural history
On 30 April 2024, ECHA notified you of a draft decision TPE-D-2114680570-48-01/D under Article 50(1) of REACH.
On 15 May 2024, you notified ECHA in REACH-IT of a cease of manufacture and import under Article 50(3) of REACH.
ECHA has received your notification of the cease of manufacture and import of the substance and as a result, your registration 01-2119453158-37-0072 is no longer valid from 15 May 2024 and you are no longer allowed to manufacture or import the Substance. You can however supply the Substance if it was manufactured or imported before 15 May 2024.
Further observations
ECHA will inform the authorities in your Member State of the invalidation of your registration. In addition, the registration number 01-2119453158-37-0072, originally assigned by ECHA decision SUB-D-2114553314-54-01/F of 26 April 2021, will be listed as ‘invalid’ on ECHA’s website.
The pending evaluation procedure that had been initiated with you is terminated in relation to your registration. No further information under Article 40, Article 41 or Article 46 of REACH will be requested from you unless you submit a new registration.
In case you have already been notified of a final decision taken by ECHA under Article 51 of REACH, that decision remains in force and you must comply with the requests set out in that decision by the set deadlines. For technical reasons, you need to contact ECHA to obtain technical instructions on the means to submit the requested information to ECHA.
In addition, under Article 50(4) of REACH, further information may still be asked from you under Article 46 of REACH (substance evaluation) in either or both of the following cases:
a. where the competent authority prepares a dossier in accordance with Annex XV concluding that there is a potential long-term risk to human health or the environment justifying the need for further information; and/or
b. where the exposure to the substance manufactured or imported by you, or to the substance in the article produced or imported by you, or to the substance used by the downstream user(s), contributes significantly to that risk.
ECHA will not reimburse any fee received for your registration.
15 May 2024
2 (2)
P.O. Box 400, FI-00121 Helsinki, Finland | Tel. +358 9 686180 | echa.europa.eu inv1/m11.0/t11.3/2024-05-15 03:37:45 dgt5.4.0
Should you have any questions please contact ECHA via the contact form at https:// echa.europa.eu/contact.
Audrey Anne Anastasi Head of Unit Directorate of Submissions and Interaction